Silexion Therapeutics Corp. (SLXN)
0.50
+0.02
(+5.26%)
USD |
NASDAQ |
May 22, 16:00
0.4673
-0.03
(-6.54%)
After-Hours: 20:00
Silexion Therapeutics EPS Diluted (Quarterly) : -0.846 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0811 |
| Pluri, Inc. | -0.5518 |
| BioLineRx Ltd. | -0.32 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 0.0716 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.733M |
| Total Expenses (Quarterly) | 2.733M |
| Enterprise Value | 1.644M |
| Earnings Yield | -1.89K% |
| Normalized Earnings Yield | -1846.08 |